| Tap a line for its trend | Currentlast close | FY22Mar 2022 |
|---|
| 83.6 | — | |
| 0.9 | 0.9 | |
| 4.0 | 4.0 | |
| 86.7 | — | |
| 2.4 | 2.4 | |
| −2.9 | −2.9 | |
| −120.3% | −120.3% | |
| −2.9 | −2.9 | |
| 4.4 | 4.4 | |
| 179.6% | 179.6% | |
| ₹16.98 | ₹16.98 | |
| −3.2 | −3.2 | |
| −3.2 | −3.2 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY22 31/03/2022 | Current last close | |
|---|---|---|---|
| Market Capitalization | — | 83.6 | |
| - Cash, Equiv & ST Investments | 0.9 | 0.9 | |
| + Total Debt | 4.0 | 4.0 | |
| Enterprise Value | — | 86.7 | |
| Revenue | 2.4 | 2.4 | |
| EBITDA | -2.9 | -2.9 | |
| Margin % | -120.33 | -120.33 | |
| EBIT | -2.9 | -2.9 | |
| Net Income | 4.4 | 4.4 | |
| Margin % | 179.59 | 179.59 | |
| EPS, Adj (current shares) | 16.98 | 16.98 | |
| Cash from Operations | -3.2 | -3.2 | |
| Free Cash Flow | -3.2 | -3.2 | |
Figures from the company's filings with NSE
In FY22 its consolidated net profit was ₹4.4 crore on revenue of ₹2.4 crore. Its debt-to-equity ratio was 0.10 on 31 March 2022.
No. Cravatex had borrowings of ₹4 crore on 31 March 2022 (consolidated balance sheet), a debt-to-equity ratio of 0.10. Its cash and current investments were ₹93 lakh, so its net debt was ₹3.1 crore.
Cravatex's debt-to-equity ratio was 0.10 on 31 March 2022: borrowings of ₹4 crore against total equity of ₹42.2 crore.
In FY22, Cravatex generated ₹3.2 crore of cash from operations and spent ₹0 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹3.2 crore. In FY19 it was −₹1.2 crore.
Cravatex's net worth — shareholders' equity in its consolidated balance sheet — was ₹42.2 crore on 31 March 2022.
Cravatex's book value per share was ₹163.17 on 31 March 2022: shareholders' equity of ₹42.2 crore divided by the 25.84 lakh shares in issue.
In 2026, Cravatex has declared one dividend: ₹13 (final) with record date 24 July 2026.
In FY22, Cravatex's return on equity (ROE) was 10.4% and its return on capital employed (ROCE) was −5.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).
Cravatex's basic earnings per share (EPS) were ₹16.98 in FY22, against ₹8.76 in FY19.
In FY22 (April 2021–March 2022), Cravatex's consolidated net profit was ₹4.4 crore, up 93.8% from ₹2.3 crore in FY19, on revenue from operations of ₹2.4 crore (up 135.1%).
From Cravatex's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.